[1] Slots J.Periodontitis: facts, fallacies and the future[J]. Periodontol 2000, 2017, 75(1): 7-23. [2] Gordon C, Amissah-Arthur MB, Gayed M, et al.The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults[J]. Rheumatology (Oxford), 2018, 57(1): e1-e45. [3] Rutter-Locher Z, Smith TO, Giles I, et al.Association between systemic lupus erythematosus and periodontitis: a systematic review and meta-analysis[J]. Front Immunol, 2017, 8: 1295. [4] Zhang Q, Zhang X, Feng G, et al.Periodontal disease in Chinese patients with systemic lupus erythematosus[J]. Rheumatol Int, 2017, 37(8): 1373-1379. [5] Calderaro DC, Ferreira GA, Corrêa JD, et al.Is chronic periodontitis premature in systemic lupus erythematosus patients?[J]. Clin Rheumatol, 2017, 36(3): 713-718. [6] Al-Mutairi KD, Al-Zahrani MS, Bahlas SM, et al.Periodontal findings in systemic lupus erythematosus patients and healthy controls[J]. Saudi Med J, 2015, 36(4): 463-468. [7] Samy E, Wax S, Huard B, et al.Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases[J]. Int Rev Immunol, 2017, 36(1): 3-19. [8] Chapple I, Mealey BL, Van Dyke TE, et al.Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions[J]. J Clin Periodontol, 2018, 45(Suppl 20): S68-S77. [9] Feletar M, Ibañez D, Urowitz MB, et al.The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed?[J]. Arthritis Rheum, 2003, 48(7): 2067-2069. [10] 孟焕新. 临床牙周病学[M]. 第2版. 北京: 北京大学医学出版社, 2014: 242-248. [11] Mendonça S, Corrêa JD, Souza AF, et al.Immunological signatures in saliva of systemic lupus erythematosus patients: influence of periodontal condition[J]. Clin Exp Rheumatol, 2019, 37(2): 208-214. [12] Rezaei M, Bayani M, Tasorian B, et al.The comparison of visfatin levels of gingival crevicular fluid in systemic lupus erythematosus and chronic periodontitis patients with healthy subjects[J]. Clin Rheumatol, 2019, 38(11): 3139-3143. [13] Zhang Q, Zhang X, Feng G, et al.Periodontal disease in Chinese patients with systemic lupus erythematosus[J]. Rheumatol Int, 2017, 37(8): 1373-1379. [14] Littlejohn E, Marder W, Lewis E, et al.The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever[J]. Lupus, 2018, 27(7): 1123-1129. [15] Stohl W.Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus(SLE)[J]. Expert Rev Clin Immunol, 2017, 13(6): 623-633. [16] Al-Mutairi KD, Al-Zahrani MS, Bahlas SM, et al.Periodontal findings in systemic lupus erythematosus patients and healthy controls[J]. Saudi Med J, 2015, 36(4): 463-468. [17] 林晓萍, 韩晓哲, 魏巍, 等. B淋巴细胞对牙周致病菌免疫反应及骨细收因子RANKL表达的影响[J].上海口腔医学, 2009, 18(4): 392-396. [18] Sete MR, Figueredo CM, Sztajnbok F.Periodontitis and systemic lupus erythematosus[J]. Rev Bras Reumatol Engl Ed, 2016, 56(2): 165-170. [19] Samy E, Wax S, Huard B, et al.Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases[J]. Int Rev Immunol, 2017, 36(1): 3-19. [20] 韩亚琨, 林晓萍. B细胞在牙周炎免疫进程中的作用机制研究[J].口腔医学, 2018, 38(1): 66-72. [21] Abe T, AlSarhan M, Benakanakere MR, et al. The B cell-stimulatory cytokines BLyS and APRIL are elevated in human periodontitis and are required for B cell-dependent bone loss in experimental murine periodontitis[J]. J Immunol, 2015, 195(4): 1427-1435. [22] Gümüs P, Nizam N, Lappin DF, et al.Saliva and serum levels of B-cell activating factors and tumor necrosis factor-alpha in patients with periodontitis[J]. J Periodontol, 2014, 85(2): 270-280. [23] Salazar-Camarena DC, Ortiz-Lazareno PC, Cruz A, et al.Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus[J]. Lupus, 2016, 25(6): 582-592. [24] Vincent FB, Kandane-Rathnayake R, Koelmeyer R, et al.Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus[J]. Clin Transl Immunology, 2019, 8(4): e1047. [25] Howe HS, Thong B, Kong KO, et al.Associations of B cell-activating factor(BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in Singapore[J]. Clin Exp Immunol, 2017, 189(3): 298-303. |